CN Patent

CN107412188A — 阿塞那平微球及其制备方法和其注射剂

Assigned to Guangzhou University of Chinese Medicine · Expires 2017-12-01 · 8y expired

What this patent protects

本发明涉及制药领域，具体涉及一种阿塞那平微球及其制备方法和其注射剂。阿塞那平微球主要由阿塞那平、聚合物载体以及乳化剂制成。阿塞那平的载量为5‑50％，优选地，阿塞那平的载量为15‑30％。该微球能够缓慢且持续释放药物，提升药物的生物利用度和治疗效果。

USPTO Abstract

本发明涉及制药领域，具体涉及一种阿塞那平微球及其制备方法和其注射剂。阿塞那平微球主要由阿塞那平、聚合物载体以及乳化剂制成。阿塞那平的载量为5‑50％，优选地，阿塞那平的载量为15‑30％。该微球能够缓慢且持续释放药物，提升药物的生物利用度和治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN107412188A
Jurisdiction
CN
Classification
—
Expires
2017-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou University of Chinese Medicine
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.